ATE250048T1 - Katalytische asymmetrische epoxidierung - Google Patents
Katalytische asymmetrische epoxidierungInfo
- Publication number
- ATE250048T1 ATE250048T1 AT97911672T AT97911672T ATE250048T1 AT E250048 T1 ATE250048 T1 AT E250048T1 AT 97911672 T AT97911672 T AT 97911672T AT 97911672 T AT97911672 T AT 97911672T AT E250048 T1 ATE250048 T1 AT E250048T1
- Authority
- AT
- Austria
- Prior art keywords
- catalytic asymmetric
- asymmetric epoxidation
- epoxidation
- catalytic
- olefin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
- C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
- C07D301/12—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with hydrogen peroxide or inorganic peroxides or peracids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
- C07D303/42—Acyclic compounds having a chain of seven or more carbon atoms, e.g. epoxidised fats
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/0825—Preparations of compounds not comprising Si-Si or Si-cyano linkages
- C07F7/083—Syntheses without formation of a Si-C bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2800996P | 1996-10-08 | 1996-10-08 | |
| PCT/US1997/018310 WO1998015544A1 (en) | 1996-10-08 | 1997-10-08 | Catalytic asymmetric epoxidation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE250048T1 true ATE250048T1 (de) | 2003-10-15 |
Family
ID=21841037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97911672T ATE250048T1 (de) | 1996-10-08 | 1997-10-08 | Katalytische asymmetrische epoxidierung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6348608B1 (de) |
| EP (1) | EP1021426B1 (de) |
| JP (1) | JP2001502316A (de) |
| AT (1) | ATE250048T1 (de) |
| AU (1) | AU4898797A (de) |
| CA (1) | CA2268255A1 (de) |
| DE (1) | DE69725023T2 (de) |
| ES (1) | ES2207721T3 (de) |
| WO (1) | WO1998015544A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6686483B2 (en) | 1996-10-08 | 2004-02-03 | Colorado State University Research Foundation | Catalytic asymmetric epoxidation |
| US6613918B1 (en) | 2000-10-20 | 2003-09-02 | Bioavailability Systems, Llc | Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates |
| CZ298749B6 (cs) | 1996-10-18 | 2008-01-16 | Vertex Pharmaceuticals Incorporated | Inhibitory serinových proteáz a farmaceutické prostředky s jejich obsahem |
| AU3567399A (en) * | 1998-04-16 | 1999-11-01 | Colorado State University Research Foundation | Kinetic resolution of olefins |
| SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
| WO2004037827A1 (en) | 2000-10-20 | 2004-05-06 | Bioavailability Systems, Llc | Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates |
| EP1386918B1 (de) * | 2001-05-11 | 2005-11-09 | Kaneka Corporation | Verfahren zur herstellung optisch aktiver epoxide |
| DE10136485C1 (de) * | 2001-07-27 | 2003-03-06 | Bayer Ag | Polyaminosäure-katalysiertes Verfahren zur enantioselektiven Epoxidierung von alpha,ß-ungesättigten Eonen und alpha,ß-ungesättigten Sulfonen |
| AU2003219702A1 (en) * | 2002-02-04 | 2003-09-02 | Colorado State University Research Foundation | Asymmetric epoxidation of electron deficient olefins |
| TW201127828A (en) | 2003-09-05 | 2011-08-16 | Vertex Pharma | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| CN101277950B (zh) * | 2005-08-02 | 2013-03-27 | 弗特克斯药品有限公司 | 丝氨酸蛋白酶抑制剂 |
| AR055395A1 (es) * | 2005-08-26 | 2007-08-22 | Vertex Pharma | Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c |
| US7964624B1 (en) | 2005-08-26 | 2011-06-21 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases |
| EP1770095A1 (de) * | 2005-09-26 | 2007-04-04 | Institut Catala D'Investigacio Quimica | Effiziente Katalysatoren zur asymmetrischen Epoxidierung von mit Elektronenmangel sowie ohne Elektronenmangel Alkenen |
| EP1770094A1 (de) * | 2005-09-26 | 2007-04-04 | Institut Catala D'Investigacio Quimica | Effiziente Synthese von asymmetrischem Epoxidierungs-Katalysator I |
| CA2643688A1 (en) | 2006-02-27 | 2007-08-30 | Vertex Pharmaceuticals Incorporated | Co-crystals and pharmaceutical compositions comprising the same |
| US20070225297A1 (en) | 2006-03-16 | 2007-09-27 | Perni Robert B | Deuterated hepatitis C protease inhibitors |
| EP1993993A1 (de) | 2006-03-16 | 2008-11-26 | Vertex Pharmaceuticals Incorporated | Verfahren und zwischenprodukte zur herstellung von sterischen verbindungen |
| EP2134717A2 (de) * | 2007-02-27 | 2009-12-23 | Vertex Pharmceuticals Incorporated | Serinprotease-hemmer |
| MX2009009182A (es) * | 2007-02-27 | 2009-09-04 | Vertex Pharma | Co-cristales y composiciones farmaceuticas que los comprenden. |
| NZ583699A (en) * | 2007-08-30 | 2012-04-27 | Vertex Pharma | Co-crystals of vx-950 (telaprevir) other components and pharmaceutical compositions comprising the same |
| CN110128439B (zh) * | 2018-02-08 | 2020-12-01 | 凯特立斯(深圳)科技有限公司 | 一种氧杂螺环化合物及其合成与拆分方法 |
| CN113227113A (zh) * | 2018-12-20 | 2021-08-06 | 帝斯曼知识产权资产管理有限公司 | 环氧化催化剂的改进合成 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5414078A (en) * | 1991-04-05 | 1995-05-09 | Emory University | Preparation of 3'-substituted-2',3'-dideoxynucleosides and 2'-deoxynucleosides from acyclic, achiral precursors |
| US5403549A (en) | 1993-11-04 | 1995-04-04 | Cyclo3 pss Medical Systems, Inc. | Method for sterilization using a fluid chemical biocide |
-
1997
- 1997-10-08 JP JP10517762A patent/JP2001502316A/ja not_active Ceased
- 1997-10-08 EP EP97911672A patent/EP1021426B1/de not_active Expired - Lifetime
- 1997-10-08 DE DE69725023T patent/DE69725023T2/de not_active Expired - Fee Related
- 1997-10-08 CA CA002268255A patent/CA2268255A1/en not_active Abandoned
- 1997-10-08 US US09/284,054 patent/US6348608B1/en not_active Expired - Fee Related
- 1997-10-08 ES ES97911672T patent/ES2207721T3/es not_active Expired - Lifetime
- 1997-10-08 AU AU48987/97A patent/AU4898797A/en not_active Abandoned
- 1997-10-08 WO PCT/US1997/018310 patent/WO1998015544A1/en not_active Ceased
- 1997-10-08 AT AT97911672T patent/ATE250048T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69725023D1 (de) | 2003-10-23 |
| EP1021426B1 (de) | 2003-09-17 |
| WO1998015544A1 (en) | 1998-04-16 |
| CA2268255A1 (en) | 1998-04-16 |
| JP2001502316A (ja) | 2001-02-20 |
| US6348608B1 (en) | 2002-02-19 |
| EP1021426A1 (de) | 2000-07-26 |
| AU4898797A (en) | 1998-05-05 |
| ES2207721T3 (es) | 2004-06-01 |
| DE69725023T2 (de) | 2004-08-05 |
| EP1021426A4 (de) | 2000-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE250048T1 (de) | Katalytische asymmetrische epoxidierung | |
| ES2113374T3 (es) | Catalizadores quirales y reacciones de epoxidacion catalizadas por los mismos. | |
| NO953617L (no) | Fremgangsmåte for rensing av taxoider | |
| PT1042314E (pt) | Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos | |
| DK0643626T3 (da) | Fremgangsmåde til fremstilling af epoxychromaner med en chiral katalysator | |
| DE3681641D1 (de) | Verfahren zur herstellung von amagnetischen bohrstrangteilen. | |
| ID16522A (id) | Katalis hidrogenasi untuk produksi hidrogen peroksida, dan metoda pembuatannya | |
| NO963247L (no) | Fremgangsmåte for epoksydering av prochirale olefiner og en katalysator for dette, samt mellomprodukter for fremstilling av katalysatoren | |
| DE60122505D1 (de) | Enzymatische umsetzung von epoxiden | |
| ATE341645T1 (de) | Verfahren für die reverse transkription | |
| NO20023150L (no) | Fremgangsmate for fremstilling av citalopram | |
| HUP9802369A3 (en) | Dinaphtazepinium salts useful as enantioselective epoxidation catalysts | |
| FR2785831B1 (fr) | Support monolithe poreux d'un element de filtration et element de filtration | |
| EA199900772A1 (ru) | Способ селективного эпоксидирования для получения лекарственных соединений | |
| ATE236141T1 (de) | Verfahren zur epoxidierung von substituierten cyclohexanonen | |
| DE3765651D1 (de) | Verfahren zur herstellung einer synthesefaser und einer orientierten synthesefaser sowie nach diesem verfahren hergestellte orientierte synthesefaser. | |
| ES2180155T3 (es) | Procedimiento en una etapa para la fabricacion de alfa-hidroxieteres mediante oxidacion de compuestos c=c insaturados con hidroperoxidos. | |
| WO1999045671A3 (en) | System for editing entertainment information by producers | |
| DE69833198D1 (de) | Mehrkanalverbindung mit reduzierter spitzen- zu durchschnittamplitude | |
| DE3578066D1 (de) | Verfahren zur herstellung von alpha, beta-diaminoacrylnitrilen. | |
| EP0629702A3 (de) | Verfahren zur Herstellung von chiralen Epoxy- oder Hydroxy-Verbindungen durch stereoselektive Epoxidierung oder Hydroxylierung. | |
| DK0688737T3 (da) | Fremgangsmåde til fremstilling af hvidt carbon | |
| BG102535A (en) | Dihydrate of (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate of 4,10 beta-diacetoxy-2 alpha-benzoyloxy-5 beta, 20-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa[g]tax-11-ene 13-alpha -yl and method for its preparaton | |
| HUP9803009A1 (hu) | Önmagából energiát előállítani és ezáltal önmagát üzemeltetni képes berendezés és energia-előállítási eljárás | |
| IT1282954B1 (it) | Processo di racemizzazione di 3-dialchilamino-1,2-propandioli chirali. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1021426 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |